Literature DB >> 11508340

Immunohistochemical study of the phosphorylated and activated form of c-Jun NH2-terminal kinase in human aorta.

H Nishio1, K Matsui, H Tsuji, A Tamura, K Suzuki.   

Abstract

c-Jun NH2-terminal kinase is a key enzyme mediating the cellular response to a variety of extracellular stimuli. In the present study, we performed immunohistochemical studies of the expression of the phosphorylated form of the kinase in 51 human aortas of various ages. The phosphorylated kinase immunoreactivity was strongly detected in vascular smooth muscle cells of the medial vessel layer of atherosclerotic lesions from adults. Immunoreactivity was also strongly detected in similar cells of the intima. On the other hand, immunoreactive phosphorylated kinase was only weakly defected in the medial vascular smooth muscle cells of non-atherosclerotic lesions from adults. We also investigated the expression of the phosphorylated kinase in infant aortas. In contrast to its weak immunoreactivity in adult non-atherosclerotic lesions, the kinase immunoreactivity was detected in high amounts in vascular smooth muscle cells of non-atherosclerotic lesions from infants. Thus, the abundant expression of the phosphorylated kinase in these cells in atherosclerotic lesions of adults and non-atherosclerotic lesions of infants suggests that the activation of c-Jun NH2-terminal kinase may be an important element initiating the proliferation of vascular smooth muscle cells during atherogenesis and aortic development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11508340     DOI: 10.1023/a:1017952310800

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  30 in total

1.  Hyperexpression and activation of extracellular signal-regulated kinases (ERK1/2) in atherosclerotic lesions of cholesterol-fed rabbits.

Authors:  Y Hu; H Dietrich; B Metzler; G Wick; Q Xu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-01       Impact factor: 8.311

Review 2.  Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases.

Authors:  A Rivard; V Andrés
Journal:  Histol Histopathol       Date:  2000-04       Impact factor: 2.303

Review 3.  How MAP kinases are regulated.

Authors:  M H Cobb; E J Goldsmith
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

4.  Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines.

Authors:  J Frostegård; A K Ulfgren; P Nyberg; U Hedin; J Swedenborg; U Andersson; G K Hansson
Journal:  Atherosclerosis       Date:  1999-07       Impact factor: 5.162

5.  Increased expression and activation of stress-activated protein kinases/c-Jun NH(2)-terminal protein kinases in atherosclerotic lesions coincide with p53.

Authors:  B Metzler; Y Hu; H Dietrich; Q Xu
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

6.  Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death.

Authors:  Z Mallat; C Heymes; J Ohan; E Faggin; G Lesèche; A Tedgui
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

Review 7.  Review of preclinical data of calcium channel blockers and atherosclerosis.

Authors:  W G Nayler
Journal:  J Cardiovasc Pharmacol       Date:  1999       Impact factor: 3.105

Review 8.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

Authors:  H C Stary; A B Chandler; R E Dinsmore; V Fuster; S Glagov; W Insull; M E Rosenfeld; C J Schwartz; W D Wagner; R W Wissler
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

9.  Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2.

Authors:  A Lin; A Minden; H Martinetto; F X Claret; C Lange-Carter; F Mercurio; G L Johnson; M Karin
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

10.  Transcription factor ATF2 regulation by the JNK signal transduction pathway.

Authors:  S Gupta; D Campbell; B Dérijard; R J Davis
Journal:  Science       Date:  1995-01-20       Impact factor: 47.728

View more
  7 in total

Review 1.  Insulin resistance and atherosclerosis.

Authors:  Babak Razani; Manu V Chakravarthy; Clay F Semenkovich
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

2.  WNT5A-JNK regulation of vascular insulin resistance in human obesity.

Authors:  Melissa G Farb; Shakun Karki; Song-Young Park; Samantha M Saggese; Brian Carmine; Donald T Hess; Caroline Apovian; Jessica L Fetterman; Rosa Bretón-Romero; Naomi M Hamburg; José J Fuster; María A Zuriaga; Kenneth Walsh; Noyan Gokce
Journal:  Vasc Med       Date:  2016-09-28       Impact factor: 3.239

3.  Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis.

Authors:  Evis Harja; Jong Sun Chang; Yan Lu; Michael Leitges; Yu Shan Zou; Ann Marie Schmidt; Shi-Fang Yan
Journal:  FASEB J       Date:  2008-11-26       Impact factor: 5.191

4.  Ultrafine particles from diesel engines induce vascular oxidative stress via JNK activation.

Authors:  Rongsong Li; Zhi Ning; Jeffery Cui; Bhavraj Khalsa; Lisong Ai; Wakako Takabe; Tyler Beebe; Rohit Majumdar; Constantinos Sioutas; Tzung Hsiai
Journal:  Free Radic Biol Med       Date:  2008-12-11       Impact factor: 7.376

5.  Deletion of JNK2 prevents vitamin-D-deficiency-induced hypertension and atherosclerosis in mice.

Authors:  Jisu Oh; Amy E Riek; Rong M Zhang; Samantha A S Williams; Isra Darwech; Carlos Bernal-Mizrachi
Journal:  J Steroid Biochem Mol Biol       Date:  2017-09-23       Impact factor: 4.292

Review 6.  The Role of PKC-MAPK Signalling Pathways in the Development of Hyperglycemia-Induced Cardiovascular Complications.

Authors:  Fatin Farhana Jubaidi; Satirah Zainalabidin; Izatus Shima Taib; Zariyantey Abdul Hamid; Nur Najmi Mohamad Anuar; Juriyati Jalil; Nor Anizah Mohd Nor; Siti Balkis Budin
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

Review 7.  Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes.

Authors:  Justin Hou Ming Yung; Adria Giacca
Journal:  Cells       Date:  2020-03-13       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.